The GLP-1 Revolution: How New Medications Are Changing Weight Loss
An in-depth look at semaglutide, tirzepatide, and the future of medical weight management.
GLP-1 receptor agonists have transformed the landscape of medical weight loss. With average weight loss of 15-25% of body weight, these medications represent a paradigm shift in obesity treatment.
How GLP-1 Medications Work
These medications mimic the GLP-1 hormone, which regulates appetite, blood sugar, and gastric emptying. By activating GLP-1 receptors in the brain, they reduce hunger and increase feelings of fullness after meals.
Semaglutide vs Tirzepatide
While both are highly effective, tirzepatide (a dual GIP/GLP-1 agonist) has shown superior weight loss results in head-to-head comparisons, with some studies showing 5-8% greater weight loss than semaglutide.
Disclaimer: This article is for educational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before starting any hormone therapy.